DekaBank Deutsche Girozentrale’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,000
| Closed | -$532K | – | 1109 |
|
|
2025
Q4 | $532K | Hold |
20,000
| – | – | ﹤0.01% | 987 |
|
|
2025
Q3 | $949K | Hold |
20,000
| – | – | ﹤0.01% | 884 |
|
|
2025
Q2 | $1.14M | Hold |
20,000
| – | – | ﹤0.01% | 839 |
|
|
2025
Q1 | $846K | Hold |
20,000
| – | – | ﹤0.01% | 877 |
|
|
2024
Q4 | $557K | Hold |
20,000
| – | – | ﹤0.01% | 981 |
|
|
2024
Q3 | $559K | Hold |
20,000
| – | – | ﹤0.01% | 993 |
|
|
2024
Q2 | $466K | Hold |
20,000
| – | – | ﹤0.01% | 1019 |
|
|
2024
Q1 | $488K | Sell |
20,000
-7,600
| -28% | -$183K | ﹤0.01% | 1004 |
|
|
2023
Q4 | $659K | Hold |
27,600
| – | – | ﹤0.01% | 984 |
|
|
2023
Q3 | $1.33M | Buy |
27,600
+6,000
| +28% | +$279K | ﹤0.01% | 824 |
|
|
2023
Q2 | $966K | Hold |
21,600
| – | – | ﹤0.01% | 886 |
|
|
2023
Q1 | $812K | Buy |
21,600
+7,600
| +54% | +$339K | ﹤0.01% | 917 |
|
|
2022
Q4 | $747K | Hold |
14,000
| – | – | ﹤0.01% | 952 |
|
|
2022
Q3 | $417K | Buy |
+14,000
| New | +$214K | ﹤0.01% | 1078 |
|
|
2022
Q2 | – | Sell |
-13,500
| Closed | -$197K | – | 1364 |
|
|
2022
Q1 | $197K | Buy |
13,500
+1,200
| +10% | +$21K | ﹤0.01% | 1211 |
|
|
2021
Q4 | $261K | Buy |
12,300
+300
| +3% | +$6.65K | ﹤0.01% | 1223 |
|
|
2021
Q3 | $266K | Hold |
12,000
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q2 | $305K | Hold |
12,000
| – | – | ﹤0.01% | 1141 |
|
|
2021
Q1 | $338K | Hold |
12,000
| – | – | ﹤0.01% | 1092 |
|
|
2020
Q4 | $301K | Buy |
+12,000
| New | +$334K | ﹤0.01% | 1120 |
|
DekaBank Deutsche Girozentrale's AKRO Position: Q1 2026 in Review
DekaBank Deutsche Girozentrale sold out of Akero Therapeutics (AKRO) in Q1 2026, closing a stake of 20,000 shares — an estimated $532K sold.
DekaBank Deutsche Girozentrale first reported a position in AKRO in Q4 2020 and held it in 20 quarters. The position peaked at $1.33M in Q3 2023. 0 funds tracked by Wall St. Rank hold AKRO as of Q1 2026.
- DekaBank Deutsche Girozentrale reported no remaining Akero Therapeutics position as of Q1 2026 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 20,000 Akero Therapeutics shares in Q1 2026, an estimated $532K.
- DekaBank Deutsche Girozentrale first reported a position in Akero Therapeutics in Q4 2020 and held it in 20 quarters.
- DekaBank Deutsche Girozentrale's Akero Therapeutics position peaked at $1.33M in Q3 2023.
- 0 funds tracked by Wall St. Rank held Akero Therapeutics as of Q1 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.